UniCom leads digital and intelligent wave with innovative achievements at MWC25

03-07

We Are Enough® Launches the 3.3.3 Challenge: A Global Movement Empowering Women Through Investing in Women

Venture Capitalist Tracy Gray Aims to Address Women\'s Wealth Gap and Access to Capital LOS ANGELES,March 6,2025-- We Are Enough (WAE),a nonprofit,launches the first of its kind initiative,the 3.3.3C

03-06

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

From many clicks to one query,drug supply managers can more quickly access,analyze,and visualize the trial supply data they need.

03-06

ScamAdviser at MWC 2025: Addressing the Rising Threat of AI-Powered Scams

BARCELONA,Spain,March 5,2025-- ScamAdviser,a leading brand in global enterprise scam prevention solutions,spotlighted the escalating threat of AI-driven scams at Mobile World Congress (MWC) 2025 durin

03-06

ARK Group Strengthens Singapore Presence with Expanded Overseas Headquarters to Power Global Growth

SINGAPORE,March 5,2025-- Noah Holdings Limited\'s ("Noah" or "the Company") (NYSE: NOAH,HKEX: 6686) newly launched global wealth management platform for global Chinese investors,AR

03-06

SanyouBio Launches 73 Whole-Series Bispecific Reference Antibody Products, Facilitating New Breakthroughs in Bispecific Drug Development

SHANGHAI,March 5,2025-- SanyouBio announced today the official launch of 73 whole-series bispecific antibody reference products,covering globally approved and representative clinical-stage bispecific

03-06

Hyundai IONIQ 9: Game-changing Electric SUV Offers Long Range, Next-level Comfort, Features and Capabilities

Powerful,efficient performance through multiple motor configurations and a long-range battery for up to 620 km WLTP-estimated range

03-06

Suvoda launches Sofia, a new AI assistant to simplify management of clinical trials

From many clicks to one query,drug supply managers can more quickly access,analyze,and visualize the trial supply data they need.

03-06

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO andSUZHOU,China,March 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures,and commercializes high-qua

03-05

ZTE to highlight "Catalyzing Intelligent Innovation" at MWC Barcelona 2025, harnessing the power of AI

BARCELONA,Spain,March 3,2025-- ZTE Corporation (0763.HK/000063.SZ),a global leading provider of integrated information and communication technology solutions,will participate in MWC Barcelona 2025 fr

03-05